Elicio Therapeutics, Inc. (ELTX)
$1.88-0.53%Close
SELLCRISIS · day 31
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $36M
- Beta
- 1.86
- P/E (TTM)
- -0.88
- Short % float
- 17.48%
- Days to cover
- 4.1
- SI change
- -6.8%
- 1W
- -2.08%
- 1M
- -8.29%
- vs SPY 1W
- -3.24%
- vs SPY 1M
- -11.28%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ELTX?
- LOPJLB’s latest quantitative signal on Elicio Therapeutics, Inc. (ELTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ELTX in?
- Elicio Therapeutics, Inc. (ELTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Elicio Therapeutics, Inc. (ELTX) do?
- Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG …